Physician profile
Ruby Satpathy
NPI 1215157136
$204,784.04
in general payments reported to CMS, 2019-2025
42 companies · $61K in 2025
The $61K reported for 2025 was more than what 98% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,664 · 2020: $650 · 2021: $5,284 · 2022: $47K · 2023: $32K · 2024: $49K · 2025: $61K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $91K · Travel and Lodging: $19K · Food and Beverage: $16K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $16K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $91,350.00 |
| Travel and Lodging | $18,716.03 |
| Food and Beverage | $16,450.89 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $15,665.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $96,856.06 | 2019-2025 | Amplatzer Amulet, Navitor, Amplatzer Talisman |
| Medtronic, INC. | $39,345.99 | 2021-2025 | Corevalve Evolut R, Apollotm, Onyx Frontier |
| Edwards Lifesciences Corporation | $29,785.15 | 2021-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Pascal, Sapien 3 Ultra Resilia |
| Cardiva Medical, INC. | $24,568.10 | 2024-2025 | Savvywire, Cardiva Vascade 6/7f Vcs, Cardiva Vascade Mvp Xl Vvcs 10-12f |
| Boston Scientific Corporation | $6,707.51 | 2019-2025 | Watchman Access System, Watchman, Rotapro |
| Abiomed | $2,397.07 | 2019-2025 | Impella |
| Aop Health US, LLC | $657.80 | 2025 | Rapiblyk |
| W. L. Gore & Associates, INC. | $439.14 | 2019-2025 | Gore Cardioform Septal Occluder |
| E.R. Squibb & Sons, L.L.C. | $435.69 | 2019-2025 | Camzyos, Eliquis |
| Novartis Pharmaceuticals Corporation | $384.32 | 2019-2025 | |
| Pfizer INC. | $352.79 | 2020-2025 | |
| Acist Medical Systems, INC. | $339.40 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $309.62 | 2019-2025 | Lifevest |
| Merck Sharp & Dohme LLC | $204.26 | 2021-2025 | Verquvo |
| Medtronic Vascular, INC. | $198.49 | 2019-2020 |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $184.88 | 2019-2024 | Xarelto |
| Kestra Medical Technology Services, INC. | $177.32 | 2024-2025 | Assure Wcd |
| Cardiovascular Systems INC. | $165.85 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $153.44 | 2024-2025 | Jardiance |
| Penumbra, INC. | $140.84 | 2021-2024 | Indigo System |
| Astrazeneca Pharmaceuticals Lp | $107.24 | 2019-2025 | Wainua |
| Amgen INC. | $91.34 | 2019-2024 | Repatha |
| Bayer Healthcare Pharmaceuticals INC. | $72.47 | 2025 | |
| Alnylam Pharmaceuticals INC. | $55.64 | 2025 | Amvuttra |
| Shockwave Medical, INC | $55.54 | 2021-2022 | |
| Novo Nordisk INC | $55.31 | 2021-2024 | Wegovy |
| Ge Healthcare | $52.05 | 2019-2025 | |
| Bridgebio Pharma, INC. | $50.20 | 2025 | Attruby |
| Cvrx, INC. | $48.43 | 2021 | |
| Haemonetics Corporation | $47.17 | 2025 | |
| Scpharmaceuticals INC. | $46.59 | 2023-2024 | |
| Artivion, INC. | $43.32 | 2023 | Photofix Decellularized Bovine Pericardium, Bioglue Surgical Adhesive, Cardiac Non-Synergraft |
| Impulse Dynamics (USA) INC. | $41.79 | 2022 | |
| Atricure, INC. | $38.89 | 2023-2024 | |
| Philips North America LLC | $30.87 | 2024 | (Ck4) Mcot |
| Astellas Pharma US INC | $28.59 | 2019-2020 | |
| Terumo Medical Corporation | $26.00 | 2024 | Metacross Otw |
| Esperion Therapeutics, INC. | $19.68 | 2025 | Nexletol |
| Amarin Pharma, INC. | $19.60 | 2022 | |
| Ionis Pharmaceuticals, INC. | $19.13 | 2025 | Tryngolza |
| Innovation Technologies INC | $16.43 | 2025 | Irrisept |
| Kiniksa Pharmaceuticals, Ltd. | $14.04 | 2023 | Arcalyst |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ruby Satpathy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.